Clinical Trial Update: Anterior Stromal Changes After PRK by Using Intraoperative Mitomicin C [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating anterior stromal changes after PRK with intraoperative mitomycin C has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Refractive Disorders

Drugs mentioned

• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Refractive Disorders | Phase 4 | Status: TERMINATED